Endocrine, behavioral and autonomic effects of neuropeptide AF

M. Jászberényi, Zsolt Bagosi, Balázs Thurzó, I. Földesi, Gyula Szabó, G. Telegdy

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The actions of neuropeptide AF (NPAF), on the hypothalamic-pituitary-adrenal (HPA) axis, behavior and autonomic functions were investigated. NPAF (0.25, 0.5, 1, 2 nmol) was administered intracerebroventricularly to rats, the behavior of which was monitored by means of telemetry, open-field (OF) observations and elevated plus-maze (EPM) tests. The temperature and heart rate were recorded by telemetry, and the plasma ACTH and corticosterone levels were used as indices of the HPA activation. The dopamine release from striatal and amygdala slices after peptide treatment (100 nM and 1 μM) was measured with a superfusion apparatus. To establish the transmission of the HPA response, animals were pretreated with the corticotrophin-releasing hormone (CRH) receptor antagonist antalarmin or astressin 2B (0.5 nmol). In the OF test, the animals were pretreated with antalarmin or haloperidol (10 μg/kg), while in the EPM test they were pretreated with antalarmin or diazepam (1 mg/kg). NPAF stimulated ACTH and corticosterone release, which was inhibited by antalarmin. It activated exploratory locomotion (square crossings and rearings) and grooming in OF observations, and decreased the entries to and the time spent in the open arms during the EPM tests. The antagonists inhibited the locomotor responses, and also attenuated grooming and the EPM responses. NPAF also increased spontaneous locomotion, and tended to decrease the core temperature and the heart rate in telemetry, while it augmented the dopamine release from striatal and amygdala slices. These results demonstrate, that acute administration of exogenous NPAF stimulates the HPA axis and behavioral paradigms through CRH and dopamine release.

Original languageEnglish
Pages (from-to)24-34
Number of pages11
JournalHormones and Behavior
Volume56
Issue number1
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Autonomic Agents
Telemetry
Corpus Striatum
Dopamine
Grooming
Locomotion
Corticosterone
Amygdala
Adrenocorticotropic Hormone
Heart Rate
Corticotropin-Releasing Hormone Receptors
Hormone Antagonists
Temperature
Corticotropin-Releasing Hormone
Haloperidol
Diazepam
A18Famide
Peptides
antalarmin

Keywords

  • ACTH
  • Corticosterone
  • Elevated plus-maze
  • Hypothalamic-pituitary-adrenal axis
  • Neuropeptide AF
  • Open-field
  • Superfusion
  • Telemetry

ASJC Scopus subject areas

  • Endocrinology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

Endocrine, behavioral and autonomic effects of neuropeptide AF. / Jászberényi, M.; Bagosi, Zsolt; Thurzó, Balázs; Földesi, I.; Szabó, Gyula; Telegdy, G.

In: Hormones and Behavior, Vol. 56, No. 1, 06.2009, p. 24-34.

Research output: Contribution to journalArticle

Jászberényi, M. ; Bagosi, Zsolt ; Thurzó, Balázs ; Földesi, I. ; Szabó, Gyula ; Telegdy, G. / Endocrine, behavioral and autonomic effects of neuropeptide AF. In: Hormones and Behavior. 2009 ; Vol. 56, No. 1. pp. 24-34.
@article{4f2cca337204464285e0ba04ab44f913,
title = "Endocrine, behavioral and autonomic effects of neuropeptide AF",
abstract = "The actions of neuropeptide AF (NPAF), on the hypothalamic-pituitary-adrenal (HPA) axis, behavior and autonomic functions were investigated. NPAF (0.25, 0.5, 1, 2 nmol) was administered intracerebroventricularly to rats, the behavior of which was monitored by means of telemetry, open-field (OF) observations and elevated plus-maze (EPM) tests. The temperature and heart rate were recorded by telemetry, and the plasma ACTH and corticosterone levels were used as indices of the HPA activation. The dopamine release from striatal and amygdala slices after peptide treatment (100 nM and 1 μM) was measured with a superfusion apparatus. To establish the transmission of the HPA response, animals were pretreated with the corticotrophin-releasing hormone (CRH) receptor antagonist antalarmin or astressin 2B (0.5 nmol). In the OF test, the animals were pretreated with antalarmin or haloperidol (10 μg/kg), while in the EPM test they were pretreated with antalarmin or diazepam (1 mg/kg). NPAF stimulated ACTH and corticosterone release, which was inhibited by antalarmin. It activated exploratory locomotion (square crossings and rearings) and grooming in OF observations, and decreased the entries to and the time spent in the open arms during the EPM tests. The antagonists inhibited the locomotor responses, and also attenuated grooming and the EPM responses. NPAF also increased spontaneous locomotion, and tended to decrease the core temperature and the heart rate in telemetry, while it augmented the dopamine release from striatal and amygdala slices. These results demonstrate, that acute administration of exogenous NPAF stimulates the HPA axis and behavioral paradigms through CRH and dopamine release.",
keywords = "ACTH, Corticosterone, Elevated plus-maze, Hypothalamic-pituitary-adrenal axis, Neuropeptide AF, Open-field, Superfusion, Telemetry",
author = "M. J{\'a}szber{\'e}nyi and Zsolt Bagosi and Bal{\'a}zs Thurz{\'o} and I. F{\"o}ldesi and Gyula Szab{\'o} and G. Telegdy",
year = "2009",
month = "6",
doi = "10.1016/j.yhbeh.2009.02.006",
language = "English",
volume = "56",
pages = "24--34",
journal = "Hormones and Behavior",
issn = "0018-506X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Endocrine, behavioral and autonomic effects of neuropeptide AF

AU - Jászberényi, M.

AU - Bagosi, Zsolt

AU - Thurzó, Balázs

AU - Földesi, I.

AU - Szabó, Gyula

AU - Telegdy, G.

PY - 2009/6

Y1 - 2009/6

N2 - The actions of neuropeptide AF (NPAF), on the hypothalamic-pituitary-adrenal (HPA) axis, behavior and autonomic functions were investigated. NPAF (0.25, 0.5, 1, 2 nmol) was administered intracerebroventricularly to rats, the behavior of which was monitored by means of telemetry, open-field (OF) observations and elevated plus-maze (EPM) tests. The temperature and heart rate were recorded by telemetry, and the plasma ACTH and corticosterone levels were used as indices of the HPA activation. The dopamine release from striatal and amygdala slices after peptide treatment (100 nM and 1 μM) was measured with a superfusion apparatus. To establish the transmission of the HPA response, animals were pretreated with the corticotrophin-releasing hormone (CRH) receptor antagonist antalarmin or astressin 2B (0.5 nmol). In the OF test, the animals were pretreated with antalarmin or haloperidol (10 μg/kg), while in the EPM test they were pretreated with antalarmin or diazepam (1 mg/kg). NPAF stimulated ACTH and corticosterone release, which was inhibited by antalarmin. It activated exploratory locomotion (square crossings and rearings) and grooming in OF observations, and decreased the entries to and the time spent in the open arms during the EPM tests. The antagonists inhibited the locomotor responses, and also attenuated grooming and the EPM responses. NPAF also increased spontaneous locomotion, and tended to decrease the core temperature and the heart rate in telemetry, while it augmented the dopamine release from striatal and amygdala slices. These results demonstrate, that acute administration of exogenous NPAF stimulates the HPA axis and behavioral paradigms through CRH and dopamine release.

AB - The actions of neuropeptide AF (NPAF), on the hypothalamic-pituitary-adrenal (HPA) axis, behavior and autonomic functions were investigated. NPAF (0.25, 0.5, 1, 2 nmol) was administered intracerebroventricularly to rats, the behavior of which was monitored by means of telemetry, open-field (OF) observations and elevated plus-maze (EPM) tests. The temperature and heart rate were recorded by telemetry, and the plasma ACTH and corticosterone levels were used as indices of the HPA activation. The dopamine release from striatal and amygdala slices after peptide treatment (100 nM and 1 μM) was measured with a superfusion apparatus. To establish the transmission of the HPA response, animals were pretreated with the corticotrophin-releasing hormone (CRH) receptor antagonist antalarmin or astressin 2B (0.5 nmol). In the OF test, the animals were pretreated with antalarmin or haloperidol (10 μg/kg), while in the EPM test they were pretreated with antalarmin or diazepam (1 mg/kg). NPAF stimulated ACTH and corticosterone release, which was inhibited by antalarmin. It activated exploratory locomotion (square crossings and rearings) and grooming in OF observations, and decreased the entries to and the time spent in the open arms during the EPM tests. The antagonists inhibited the locomotor responses, and also attenuated grooming and the EPM responses. NPAF also increased spontaneous locomotion, and tended to decrease the core temperature and the heart rate in telemetry, while it augmented the dopamine release from striatal and amygdala slices. These results demonstrate, that acute administration of exogenous NPAF stimulates the HPA axis and behavioral paradigms through CRH and dopamine release.

KW - ACTH

KW - Corticosterone

KW - Elevated plus-maze

KW - Hypothalamic-pituitary-adrenal axis

KW - Neuropeptide AF

KW - Open-field

KW - Superfusion

KW - Telemetry

UR - http://www.scopus.com/inward/record.url?scp=67349147883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349147883&partnerID=8YFLogxK

U2 - 10.1016/j.yhbeh.2009.02.006

DO - 10.1016/j.yhbeh.2009.02.006

M3 - Article

C2 - 19269292

AN - SCOPUS:67349147883

VL - 56

SP - 24

EP - 34

JO - Hormones and Behavior

JF - Hormones and Behavior

SN - 0018-506X

IS - 1

ER -